Yes, Levodopa-Carbidopa Can Cause Orange-Colored Urine
Levodopa-carbidopa commonly causes orange, red, brown, or black discoloration of urine, and this is a clinically insignificant side effect that patients should be reassured about. 1, 2
What Patients Need to Know
The FDA drug labels for both levodopa and carbidopa explicitly state that "occasionally, dark color (red, brown, or black) may appear in saliva, urine, or sweat after ingestion" of these medications 1, 2. This discoloration:
- Appears to be clinically insignificant - it does not indicate harm or toxicity
- Can also affect saliva and sweat, potentially discoloring garments
- Is related to the color of the medication and its metabolites 3
- Does not require discontinuation of the medication
Clinical Context
This urine discoloration is a well-recognized, benign side effect of levodopa therapy. The metabolites of levodopa are naturally pigmented compounds that are excreted in bodily fluids. When COMT inhibitors (like entacapone or tolcapone) are added to levodopa therapy, urine discoloration to "dark yellow or orange" becomes even more common, as these medications and their metabolites are also colored 3.
Important Caveat
While orange urine from levodopa-carbidopa is harmless, clinicians should ensure patients understand this is expected so they don't mistake it for:
- Hematuria (blood in urine)
- Bilirubinuria (liver dysfunction)
- Other pathological causes of urine discoloration
Patients should be counseled about this side effect when starting therapy to prevent unnecessary alarm and avoid premature discontinuation of an effective medication.